The Blue Cross Blue Shield Association (BCBSA) released a report called Childhood Allergies in America. The study showed that allergy rates among children have been going up from 2010 to 2016.
Today, the U.S. Environmental Protection Agency (EPA) awarded more than $8.7 million to replace or retrofit 452 older diesel school buses. The funds are going to 141 school bus fleets in 32 states, each of which will receive rebates through EPA's Diesel Emissions Reduction Act (DERA) funding. The new and retrofitted buses will reduce pollutants that are linked to health problems such as asthma and lung damage.
Researchers have found that temporarily increasing the dosage of inhaled steroids when asthma symptoms begin to worsen does not effectively prevent severe flare-ups, and may be associated with slowing a child’s growth, challenging a common medical practice involving children with mild-to-moderate asthma.
As part of the U.S. Food and Drug Administration’s ongoing efforts to protect consumers from health fraud, the agency is reminding consumers to be wary of unapproved products claiming to prevent, treat or cure influenza, or flu. This year’s severe flu season raises new concerns about the potential for consumers to be lured into buying unproven flu treatments, and even worse, buying counterfeit antivirals online from websites that appear to be legitimate online pharmacies.
Asthma and Allergy Foundation of America Study Shows A Higher Burden of Disease for Patients with Adult- and Late Childhood-onset Atopic Dermatitis vs Patients with Early Childhood-onset Atopic Dermatitis WASHINGTON, D.C. (March 4, 2018) - The Asthma and Allergy Foundation of America (AAFA) today announced data demonstrating a higher burden of disease for patients with adult- and late childhood-onset atopic dermatitis (AD) vs patients with early childhood-onset AD. These results are from the...
QVAR® RediHaler™ (beclomethasone dipropionate HFA) Inhalation Aerosol is now available to patients by prescription! It is the first and only breath-actuated inhaled corticosteroid for the maintenance treatment of asthma in patients ages 4 and older. QVAR® RediHaler™ is not used to relieve sudden breathing problems and won’t replace a rescue inhaler.
According to the Food and Drug Administration (FDA), Mylan is discontinuing Aerospan® (80 mcg). Aerospan is a corticosteroid inhaler used for daily asthma maintenance. Mylan notified the FDA on Jan. 26, 2018.
The Asthma and Allergy Foundation of America (AAFA) cautions parents raising children with food allergies that some scenes in the newly-released “Peter Rabbit” film may be disturbing for young viewers with food allergies. In the film, a character with a known food allergy to blackberries is attacked with them. This leads to a severe allergic reaction known as anaphylaxis and the need to use a lifesaving injection of the drug epinephrine.
QVAR® RediHaler™ (beclomethasone dipropionate HFA) Inhalation Aerosol will become available by prescription on February 12, 2018. QVAR® (beclomethasone dipropionate HFA) Inhalation Aerosol will no longer be available to patients.
FDA's most prominent warning, the Boxed Warning, about asthma-related death has been removed from the drug labels of medicines that contain both an ICS and LABA. A FDA review of four large clinical safety trials shows that treating asthma with long-acting beta agonists (LABAs) in combination with inhaled corticosteroids (ICS) does not result in significantly more serious asthma-related side effects than treatment with ICS alone.
Combining a 16-week initial course of the medication omalizumab with oral immunotherapy (OIT) greatly improves the efficacy of OIT for children with allergies to multiple foods, new clinical trial findings show. After 36 weeks, more than 80 percent of children who received omalizumab and OIT could safely consume two-gram portions of at least two foods to which they were allergic, compared with only a third of children who received placebo and OIT.
More than 10 years ago, U.S. tobacco companies were ordered to run ads about the bad effects of tobacco products. On Nov. 26, 2017, the court-ordered ads began. Tobacco smoke can cause a lot of damage to your health, even if you aren’t the one smoking. In 2006, a court found several major tobacco companies guilty of misleading the public about the dangers of tobacco products. The companies are finally running ads in major newspapers and on TV stations. These ads have to include specific...
Asthma research methods have been changing during the past several years. Research is more effective when researchers and patients work together to better understand asthma and find new treatments. At the Asthma and Allergy Foundation of America (AAFA), we feel your voice is valuable in asthma research. We support efforts to help you be an active part of the future of asthma management and treatments.
Some people are hesitant to participate in research. This may be because of fear of the unknown or from past stories. But today, patients have rights to protect them during research studies. Before you join a study, you will asked to sign an informed consent document.
We need asthma research so experts can find and create new treatments for asthma, and hopefully a cure. Experts decide what research is needed by looking at the effects of asthma.